215 related articles for article (PubMed ID: 15929796)
1. Hepatocellular carcinoma and the penetrance of HFE C282Y mutations: a cross sectional study.
Willis G; Bardsley V; Fellows IW; Lonsdale R; Wimperis JZ; Jennings BA
BMC Gastroenterol; 2005 Jun; 5():17. PubMed ID: 15929796
[TBL] [Abstract][Full Text] [Related]
2. Penetrance, cancer incidence and survival in HFE haemochromatosis-A population-based cohort study.
Schaefer B; Pammer LM; Pfeifer B; Neururer S; Troppmair MR; Panzer M; Wagner S; Pertler E; Gieger C; Kronenberg F; Lamina C; Tilg H; Zoller H
Liver Int; 2024 Mar; 44(3):838-847. PubMed ID: 38263707
[TBL] [Abstract][Full Text] [Related]
3. Incidence of liver disease in people with HFE mutations.
Willis G; Wimperis JZ; Lonsdale R; Fellows IW; Watson MA; Skipper LM; Jennings BA
Gut; 2000 Mar; 46(3):401-4. PubMed ID: 10673304
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma.
Fargion S; Stazi MA; Fracanzani AL; Mattioli M; Sampietro M; Tavazzi D; Bertelli C; Patriarca V; Mariani C; Fiorelli G
Blood Cells Mol Dis; 2001; 27(2):505-11. PubMed ID: 11500061
[TBL] [Abstract][Full Text] [Related]
5. Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis: Associations in a large community cohort.
Pilling LC; Atkins JL; Melzer D
Hepatology; 2022 Dec; 76(6):1735-1745. PubMed ID: 35567766
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of common HFE and SERPINA1 mutations in patients with hepatocellular carcinoma in a Moroccan population.
Ezzikouri S; El Feydi AE; El Kihal L; Afifi R; Benazzouz M; Hassar M; Chafik A; Pineau P; Benjelloun S
Arch Med Res; 2008 Feb; 39(2):236-41. PubMed ID: 18164971
[TBL] [Abstract][Full Text] [Related]
7. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the HFE gene in patients with hepatocellular carcinoma.
Cauza E; Peck-Radosavljevic M; Ulrich-Pur H; Datz C; Gschwantler M; Schöniger-Hekele M; Hackl F; Polli C; Rasoul-Rockenschaub S; Müller C; Wrba F; Gangl A; Ferenci P
Am J Gastroenterol; 2003 Feb; 98(2):442-7. PubMed ID: 12591066
[TBL] [Abstract][Full Text] [Related]
9. Penetrance of the C28Y/C282Y genotype of the HFE gene.
Asberg A; Hveem K; Kannelønning K; Irgens WØ
Scand J Gastroenterol; 2007 Sep; 42(9):1073-7. PubMed ID: 17710673
[TBL] [Abstract][Full Text] [Related]
10. Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?
Cadet E; Capron D; Gallet M; Omanga-Léké ML; Boutignon H; Julier C; Robson KJ; Rochette J
J Med Genet; 2005 May; 42(5):390-5. PubMed ID: 15863667
[TBL] [Abstract][Full Text] [Related]
11. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk in HFE C282Y homozygotes: results from the HUNT 2 study.
Asberg A; Thorstensen K; Irgens WØ; Romundstad PR; Hveem K
Scand J Gastroenterol; 2013 Feb; 48(2):189-95. PubMed ID: 23281741
[TBL] [Abstract][Full Text] [Related]
13. Contribution of different HFE genotypes to iron overload disease: a pooled analysis.
Burke W; Imperatore G; McDonnell SM; Baron RC; Khoury MJ
Genet Med; 2000; 2(5):271-7. PubMed ID: 11399207
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis.
Boige V; Castéra L; de Roux N; Ganne-Carrié N; Ducot B; Pelletier G; Beaugrand M; Buffet C
Gut; 2003 Aug; 52(8):1178-81. PubMed ID: 12865278
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients.
Phatak PD; Ryan DH; Cappuccio J; Oakes D; Braggins C; Provenzano K; Eberly S; Sham RL
Blood Cells Mol Dis; 2002; 29(1):41-7. PubMed ID: 12482402
[TBL] [Abstract][Full Text] [Related]
16. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
[TBL] [Abstract][Full Text] [Related]
17. Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes.
Natarajan Y; Patel P; Chu J; Yu X; Hernaez R; El-Serag H; Kanwal F
Dig Dis Sci; 2023 Jan; 68(1):312-322. PubMed ID: 35790703
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver.
Blanc JF; De Ledinghen V; Bernard PH; de Verneuil H; Winnock M; Le Bail B; Carles J; Saric J; Balabaud C; Bioulac-Sage P
J Hepatol; 2000 May; 32(5):805-11. PubMed ID: 10845668
[TBL] [Abstract][Full Text] [Related]
19. Clinical penetrance of C282Y homozygous HFE hemochromatosis.
Rossi E; Olynyk JK; Jeffrey GP
Expert Rev Hematol; 2008 Dec; 1(2):205-16. PubMed ID: 21082925
[TBL] [Abstract][Full Text] [Related]
20. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.
Sikorska K; Romanowski T; Stalke P; Iżycka-Świeszewska E; Bielawski KP
Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):270-5. PubMed ID: 21669570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
